Oncolytic Virus Immunotherapy Market
Oncolytic Virus Immunotherapy Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Oncolytic Virus Immunotherapy Market Size and Growth
The Oncolytic Virus Immunotherapy market is poised for significant growth, driven by increasing cancer prevalence and advancements in viral engineering. The market size is projected to reach approximately $5 billion by 2028, fueled by rising investment in research, collaborations, and the development of novel therapeutic applications in oncology. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Merck
◍ Amgen
◍ TILT Biotherapeutics
◍ Oncorus
◍ Sorrento Therapeutics
◍ Shanghai Sunway Biotech
The Oncolytic Virus Immunotherapy market is expanding, with companies like Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics, and Shanghai Sunway Biotech pioneering innovative therapies. These firms leverage advanced viral technologies and clinical trials to drive market growth.
Sales Revenue Highlights:
- Merck: $59 billion (2022)
- Amgen: $26 billion (2022)
- Sorrento Therapeutics: $23 million (2022)
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
◍ Ambulatory Surgical Centers
By Product
◍ Engineering Oncolytic Viruses
◍ Wild-Type Oncolytic Viruses
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
